한글목차

백일해 백신 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 56억 5,000만 달러에서 2026년에는 58억 2,000만 달러에 이르고, CAGR 2.9%의 성장이 전망되고 있습니다. 지난 몇 년간 성장 요인으로는 높은 소아 예방접종률, 정부 주도의 국가 예방접종 프로그램, 백일해의 과거 유행, 백일해 백신의 정기 예방접종 일정에 백일해 백신 포함, 전세포 백신의 가용성 등을 들 수 있습니다.

백일해 백신 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 68억 2,000만 달러에 이르고, CAGR은 4.1%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 성인 백일해 백신 접종에 대한 인식 개선, 임산부 예방접종 권장 증가, 백신의 안전성 및 유효성 향상, 신흥국의 의료 접근성 확대, 복합백신 개발의 진전 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 무세포 백일해 백신 채택 확대, 추가 접종 프로그램에 대한 관심 증가, 백일해 포함 혼합백신의 보급 확대, 성인 및 임산부 백일해 백신 접종 증가, 정부 주도의 예방접종 정책 강화 등을 들 수 있습니다.

향후 몇 년간 백일해 백신 시장의 성장은 출산율 증가에 의해 주도될 것으로 예측됩니다. 출산은 태아가 모체의 자궁 내에서 성장하는 임신 기간의 종료와 자궁 밖에서 생명의 시작을 알리는 아이를 낳는 과정을 말합니다. 백일해 백신은 주로 소아에게 접종되며, 백일해 및 기타 생명을 위협할 수 있는 심각한 질병으로부터 어린이를 보호하는 역할을 합니다. 예를 들어, 미국 질병예방통제센터(CDC)가 발표한 보고서에 따르면, 2023년 1월 기준 미국의 출생 등록 건수는 전년 대비 1% 증가한 366만 4,292건으로 집계됐습니다. 이러한 출산율 증가가 백일해 백신 시장의 성장을 견인하고 있습니다.

백일해 백신 시장에서 활동하는 주요 기업들은 임산부와 영유아의 백일해 예방을 강화하기 위해 첨단 예방접종 솔루션 개발 및 규제 당국의 승인 획득에 주력하고 있습니다. 이러한 노력은 백일해 백신의 접근성 향상, 임신 중 백신 사용 권장 확대, 신생아 백일해 관련 합병증 감소를 목표로 하고 있습니다. 예를 들어, 2023년 1월 프랑스에 본사를 둔 바이오 제약사 사노피(Sanofi S.A.)는 미국 FDA로부터 임신 후기에 자사 Adacel(Tdap) 백신의 사용 확대에 대한 승인을 획득했습니다. 이로써 생후 2개월 미만의 영아에게 백일해 감염 위험이 가장 높은 생후 2개월 미만의 영아를 보호하기 위해 임산부에게 예방접종을 할 수 있게 되었습니다. 이번 승인으로 의료진은 임산부에게 예방접종을 실시할 수 있게 되어, 출생 전에 보호 항체가 태아에게 전달될 수 있게 되었습니다. 이를 통해 영아가 스스로 예방접종을 받을 수 있을 때까지 생후 초기부터 보호할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

The pertussis vaccine is a vaccine that provides protection against whooping cough (pertussis), a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thereby reducing the risk of infection and its associated symptoms.

The main products of the pertussis vaccine are the DTaP (diphtheria, tetanus, and acellular pertussis) vaccine and the TDaP (tetanus, diphtheria, and pertussis) vaccine. The DTaP vaccine, also known as the DTP vaccine, is a combination vaccine that protects against three serious bacterial infections: diphtheria, tetanus, and pertussis (whooping cough). These vaccines are available in whole-cell and acellular forms and are administered to children, adults, and infants by various end users, including vaccination centers, hospitals, and clinics.

Tariffs have created cost pressures in the pertussis vaccine market by increasing prices of imported active pharmaceutical ingredients, biologics raw materials, and specialized manufacturing equipment. these impacts are most pronounced in acellular vaccine production, combination vaccines, and supply chains serving asia-pacific, europe, and north america, where cross-border sourcing is common. pediatric and combination vaccine segments face margin pressure due to limited pricing flexibility in public immunization programs. however, tariffs are also encouraging localized manufacturing, regional supply chain resilience, and domestic vaccine production investments, supporting long-term market stability.

The pertussis vaccine market research report is one of a series of new reports from The Business Research Company that provides pertussis vaccine market statistics, including pertussis vaccine industry global market size, regional shares, competitors with a pertussis vaccine market share, detailed pertussis vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the pertussis vaccine industry. This pertussis vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.65 billion in 2025 to $5.82 billion in 2026 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to high childhood immunization coverage, government-led national vaccination programs, historical outbreaks of whooping cough, inclusion of pertussis vaccine in routine immunization schedules, availability of whole-cell vaccines.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.82 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising awareness of adult pertussis vaccination, increasing maternal immunization recommendations, advancements in vaccine safety and efficacy, expansion of healthcare access in emerging economies, growth in combination vaccine development. Major trends in the forecast period include rising adoption of acellular pertussis vaccines, increasing focus on booster immunization programs, expansion of combination vaccines including pertussis, growing adult and maternal pertussis vaccination, strengthening government immunization initiatives.

Rising childbirth rates are expected to drive the growth of the pertussis vaccine market in the coming years. Childbirth refers to the process of giving birth to a child, marking the end of pregnancy during which the fetus develops in the mother's uterus and the beginning of life outside the womb. The pertussis vaccine is primarily administered to children to protect them from whooping cough and other serious, potentially life-threatening illnesses. For instance, in January 2023, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health organization, the United States saw a 1% increase in registered births, totaling 3,664,292 compared to 2022. Therefore, rising childbirth rates are driving the growth of the pertussis vaccine market.

Major companies operating in the pertussis vaccine market are focusing on developing advanced immunization solutions and obtaining regulatory approvals to enhance maternal and infant protection against whooping cough. These initiatives aim to improve vaccine accessibility, expand recommended use during pregnancy, and reduce pertussis-related complications among newborns. For instance, in January 2023, Sanofi S.A., a France-based biopharmaceutical company, received U.S. FDA approval for the expanded use of its Adacel (Tdap) vaccine during the third trimester of pregnancy, allowing maternal immunization to help protect infants under two months of age, who are at the highest risk of severe pertussis infection. This approval enables healthcare providers to immunize pregnant individuals so that protective antibodies are transferred to the newborn before birth, providing early-life protection until the infant can receive their own vaccinations.

In June 2025, BioNet-Asia Co. Ltd., a Thailand-based vaccine biotech group with headquarters in France, partnered with PT Bio Farma to develop and distribute a combined TdaP vaccine (tetanus, diphtheria, and acellular recombinant pertussis) across the ASEAN region. These partnerships aim to strengthen regional healthcare by improving access to essential vaccines, enhancing local manufacturing capabilities, and increasing ASEAN's preparedness against infectious diseases. Perseroan Terbatas Bio Farma (Persero) is an Indonesia-based company that provides vaccines to protect against pertussis (whooping cough).

Major companies operating in the pertussis vaccine market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, CSL Limited, Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

North America was the largest region in the pertussis vaccine market in 2025. The regions covered in the pertussis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pertussis vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pertussis vaccine market consists of sales of adacel, daptacel, infanrix, kinrix, pediarix, pentacel and quadracel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pertussis Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pertussis vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pertussis vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pertussis vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
• 2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine
• 3) By Application: Children; Adults; Infants
• 4) By End-User: Vaccination Centers; Hospitals; Clinics
• Subsegments:
• 1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine; Combination Vaccines With DTaP
• 2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine; Adult Tdap Vaccine
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Sanofi Pasteur SA; CSL Limited; Serum Institute of India; Biological E. Limited; Bharat Biotech International Limited; Panacea Biotec Limited; PT Bio Farma; Walvax Biotechnology Co. Ltd.; Beijing Minhai Biotechnology Co. Ltd.; Wuhan Institute of Biological Products; Changchun Changsheng Life Sciences; Changsheng Bio-Technology Co. Ltd.; Chiron Corporation; Sinovac Biotech Ltd.; Takeda Pharmaceutical Company; Novartis AG; Johnson & Johnson
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pertussis Vaccine Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pertussis Vaccine Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pertussis Vaccine Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pertussis Vaccine Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Acellular Pertussis Vaccines
  • 4.2.2 Increasing Focus On Booster Immunization Programs
  • 4.2.3 Expansion Of Combination Vaccines Including Pertussis
  • 4.2.4 Growing Adult And Maternal Pertussis Vaccination
  • 4.2.5 Strengthening Government Immunization Initiatives

5. Pertussis Vaccine Market Analysis Of End Use Industries

• 5.1 Vaccination Centers
• 5.2 Hospitals
• 5.3 Clinics
• 5.4 Public Health Agencies
• 5.5 Maternal And Child Health Centers

6. Pertussis Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pertussis Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pertussis Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pertussis Vaccine Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pertussis Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pertussis Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pertussis Vaccine Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pertussis Vaccine Market Segmentation

• 9.1. Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
• 9.2. Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Whole-Cell Vaccine, Acellular Vaccine
• 9.3. Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Children, Adults, Infants
• 9.4. Global Pertussis Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vaccination Centers, Hospitals, Clinics
• 9.5. Global Pertussis Vaccine Market, Sub-Segmentation Of DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pediatric DTaP Vaccine, Combination Vaccines With DTaP
• 9.6. Global Pertussis Vaccine Market, Sub-Segmentation Of Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adolescent Tdap Vaccine, Adult Tdap Vaccine

10. Pertussis Vaccine Market Regional And Country Analysis

• 10.1. Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pertussis Vaccine Market

• 11.1. Asia-Pacific Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pertussis Vaccine Market

• 12.1. China Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pertussis Vaccine Market

• 13.1. India Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pertussis Vaccine Market

• 14.1. Japan Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pertussis Vaccine Market

• 15.1. Australia Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pertussis Vaccine Market

• 16.1. Indonesia Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pertussis Vaccine Market

• 17.1. South Korea Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pertussis Vaccine Market

• 18.1. Taiwan Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pertussis Vaccine Market

• 19.1. South East Asia Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pertussis Vaccine Market

• 20.1. Western Europe Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pertussis Vaccine Market

• 21.1. UK Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pertussis Vaccine Market

• 22.1. Germany Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pertussis Vaccine Market

• 23.1. France Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pertussis Vaccine Market

• 24.1. Italy Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pertussis Vaccine Market

• 25.1. Spain Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pertussis Vaccine Market

• 26.1. Eastern Europe Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pertussis Vaccine Market

• 27.1. Russia Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pertussis Vaccine Market

• 28.1. North America Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pertussis Vaccine Market

• 29.1. USA Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pertussis Vaccine Market

• 30.1. Canada Pertussis Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pertussis Vaccine Market

• 31.1. South America Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pertussis Vaccine Market

• 32.1. Brazil Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pertussis Vaccine Market

• 33.1. Middle East Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pertussis Vaccine Market

• 34.1. Africa Pertussis Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pertussis Vaccine Market, Segmentation By Product Type, Segmentation By Vaccine Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pertussis Vaccine Market Regulatory and Investment Landscape

36. Pertussis Vaccine Market Competitive Landscape And Company Profiles

• 36.1. Pertussis Vaccine Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pertussis Vaccine Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pertussis Vaccine Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

37. Pertussis Vaccine Market Other Major And Innovative Companies

• Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

38. Global Pertussis Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pertussis Vaccine Market

40. Pertussis Vaccine Market High Potential Countries, Segments and Strategies

• 40.1 Pertussis Vaccine Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pertussis Vaccine Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pertussis Vaccine Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer